Arkolith/Insider Trading/ZNTL/Form 4

Bunker Kevin D.

Chief Scientific OfficerZentalis Pharmaceuticals, Inc. (ZNTL) · full profile →Form 4 · filed Dec 21, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 20, 2023Gift(G)24K—$0835K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001725160-23-000203) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML